Schnitzler’s syndrome – Patient Worthy

byrev / Pixabay

Drug Label Expanded in the UK for Treating Rare Inflammatory Diseases

Post author:James Moore
Post published:August 10, 2018
Post category:Adult onset Still's disease Cryopyrin-Associated Periodic Syndromes Juvenile idiopathic arthritis Schnitzler Syndrome

According to a story from Hospital Healthcare Europe, The European Medicines Agency approved Kineret last year, an anti-inflammatory drug developed by Sobi. In the UK, Kineret is an approved treatment…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More